Literature DB >> 18588927

Interferon antagonist function of Japanese encephalitis virus NS4A and its interaction with DEAD-box RNA helicase DDX42.

Cheng-Wen Lin1, Chieh-Wen Cheng, Tsuey-Ching Yang, Shih-Wein Li, Mei-Hsiu Cheng, Lei Wan, Ying-Ju Lin, Chih-Ho Lai, Wei-Yong Lin, Ming-Ching Kao.   

Abstract

The interferon (IFN) antagonists of Japanese encephalitis virus (JEV) proteins contribute to the JE pathogenesis. Most flavivirus non-structural (NS) proteins correlate with virus-induced inflammation and immune escape. NS4A proteins of West Nile virus and dengue type 2 virus have been demonstrated to inhibit IFN signaling. In this study, JEV NS4A without the C-terminal 2K domain has been demonstrated to partially block activation of an IFN-stimulated response element (ISRE)-based cis-reporter by IFN-alpha/beta. In addition, JEV NS4A significantly inhibited the phosphorylation levels of STAT1 and STAT2, but not TYK2 in the IFN-treated cells. Moreover, the N-terminus of a RNA helicase DDX42 protein identified using a phage display human brain cDNA library have been demonstrated to specifically bind to JEV NS4A in vitro using a co-immunoprecipitation assay. The interaction between JEV NS4A and RNA helicase DDX42 showed partial co-localization in human medulloblastoma TE-671 cells by confocal microscopy. Importantly, the expression of N-terminal DDX42 is able to overcome JEV-induced antagonism of IFN responses. Therefore, these results show that JEV NS4A without the C-terminal 2K domain is associated with modulation of the IFN response and the interaction of JEV NS4A with RNA helicase DDX42 could be important for JE pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18588927     DOI: 10.1016/j.virusres.2008.05.015

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  21 in total

1.  Formation of chimeric genes by copy-number variation as a mutational mechanism in schizophrenia.

Authors:  Caitlin Rippey; Tom Walsh; Suleyman Gulsuner; Matt Brodsky; Alex S Nord; Molly Gasperini; Sarah Pierce; Cailyn Spurrell; Bradley P Coe; Niklas Krumm; Ming K Lee; Jonathan Sebat; Jon M McClellan; Mary-Claire King
Journal:  Am J Hum Genet       Date:  2013-10-03       Impact factor: 11.025

2.  Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice.

Authors:  Gregory D Gromowski; Cai-Yen Firestone; José Bustos-Arriaga; Stephen S Whitehead
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

3.  Japanese encephalitis virus utilizes the canonical pathway to activate NF-kappaB but it utilizes the type I interferon pathway to induce major histocompatibility complex class I expression in mouse embryonic fibroblasts.

Authors:  Sojan Abraham; Ashwini Sankrepatna Nagaraj; Soumen Basak; Ramanathapuram Manjunath
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

Review 4.  DEAD-box helicases: posttranslational regulation and function.

Authors:  Eric A Gustafson; Gary M Wessel
Journal:  Biochem Biophys Res Commun       Date:  2010-03-03       Impact factor: 3.575

5.  Immune Evasion Strategies Used by Zika Virus to Infect the Fetal Eye and Brain.

Authors:  Branden R Nelson; Justin A Roby; William B Dobyns; Lakshmi Rajagopal; Michael Gale; Kristina M Adams Waldorf
Journal:  Viral Immunol       Date:  2019-11-05       Impact factor: 2.257

6.  North American West Nile virus genotype isolates demonstrate differential replicative capacities in response to temperature.

Authors:  Christy C Andrade; Payal D Maharaj; William K Reisen; Aaron C Brault
Journal:  J Gen Virol       Date:  2011-07-20       Impact factor: 3.891

7.  Delayed cytosolic exposure of Japanese encephalitis virus double-stranded RNA impedes interferon activation and enhances viral dissemination in porcine cells.

Authors:  Lyre Anni Espada-Murao; Kouichi Morita
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

Review 8.  West Nile Virus: biology, transmission, and human infection.

Authors:  Tonya M Colpitts; Michael J Conway; Ruth R Montgomery; Erol Fikrig
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Dengue virus inhibits immune responses in Aedes aegypti cells.

Authors:  Shuzhen Sim; George Dimopoulos
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

Review 10.  Progress on the development of therapeutics against West Nile virus.

Authors:  Michael S Diamond
Journal:  Antiviral Res       Date:  2009-06-06       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.